home / stock / roiv / roiv articles


ROIV Articles, Roivant Sciences Ltd. - From 05/22/24

Stock Information

Company Name: Roivant Sciences Ltd.
Stock Symbol: ROIV
Market: NASDAQ
Website: roivant.com

Menu

ROIV ROIV Quote ROIV Short ROIV News ROIV Articles ROIV Message Board
Get ROIV Alerts

News, Short Squeeze, Breakout and More Instantly...

Vivek Ramaswamy Breathes New Life Into Beaten Down BuzzFeed Stock: What's Going On? | Benzinga

On Wednesday, BuzzFeed Inc (NASDAQ:BZFD) shares gained after former republican Presidential candidate Vivek Ramaswamy took a 7....

Vivek Ramaswamy Breathes New Life In Beaten Down BuzzFeed Stock: What's Going On? | Benzinga

On Wednesday, BuzzFeed Inc (NASDAQ:BZFD) shares gained after former republican Presidential candidate Vivek Ramaswamy took a 7....

Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provide Business Update on Thursday, May 30, 2024 | Benzinga

BASEL, Switzerland and LONDON and NEW YORK, May 16, 2024 (GLOBE NEWSWIRE) -- Roivant (NASDAQ:ROIV) today announced that it will host a live conf...

Vivek Ramaswamy-Founded Roivant's Anti-Inflammatory Drug Aces Mid-Stage Study | Benzinga

Tuesday, Roivant Sciences (NASDAQ:ROIV) and Priovant Therapeutics announced results from the Phase 2 study (NEPTUNE) evaluating brepociti...

5 Value Stocks In The Healthcare Sector | Benzinga

What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future g...

Roivant Reports Financial Results for the Third Quarter Ended December 31, 2023, and Provides Business Update | Benzinga

BASEL, Switzerland and LONDON and NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Roivant (NASDAQ:ROIV) today reported its financial results for the...

Roivant to Report Financial Results for the Third Quarter Ended December 31, 2023, and Provide Business Update on Tuesday, February 13, 2024 | Benzinga

BASEL, Switzerland and LONDON and NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Roivant (NASDAQ:ROIV) today announced that it will host a live con...

Analyst Highlights Aclaris Therapeutics' Encouraging Efficacy For Eczema Candidate, But Cautions On Data Variations | Benzinga

Wednesday, Aclaris Therapeutics Inc (NASDAQ: ACRS) released topline results from its Phase 2b study of ATI-1777, an investigational topic...

Autoimmune Disease Player Immunovant's Investigational Drug For Immune System Disorder Shows Response Rates Of Over 50% | Benzinga

Immunovant Inc (NASDAQ: IMVT), on Thursday, released the results from the initial cohort of patients in an ongoing 24-week Phase 2 trial of ba...

FedEx Posts Downbeat Earnings, Joins Steelcase, argenx And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session | Benzinga

U.S. stock futures were lower this morning, with the Dow Jones futures falling around 30 points on Wednesday. Shares of FedEx Corporation (NYSE: F...

Previous 10 Next 10